Skip to main content
Back to Kleiner Perkins

Kleiner Perkins's Medical Portfolio

Browse 7 Medical companies funded by Kleiner Perkins. See funding amounts, founder contacts, and investment details.

Medical Companies
7
Total Funding in Medical
$826.1M

Medical Portfolio Companies (7)

Export
Artificial Intelligence (AI)Health CareInformation TechnologyMedical

Ambience Healthcare develops an AI operating system used for documentation, coding, and clinical workflows in healthcare organizations.

San Francisco, United States
July 2025
$243.0M
Series C

Founder Contacts

19,000+ verified contacts

Clinical TrialsHealth CareMedical DeviceTherapeutics

Developed the first FDA-cleared digital therapeutic that significantly reduces/eliminates symptoms of panic attacks & PTSD in only 28 days

Kirkland, United States
April 2024
$22.6M
Series E

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceuticalSoftware

Biogenesis is building the end-to-end platform for clinical research.

Palo Alto, United States
March 2024
$2.5M
Seed

Founder Contacts

19,000+ verified contacts

Health CareHome Health CareHospitalMedical

MedArrive is a healthcare logistics platform that connects patients with on-demand medical transportation and care.

New York, United States
April 2023
$8.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Clinical TrialsMedicalSaaSSearch Engine

OpenEvidence is a medical AI company that builds a search engine to support clinicians in making evidence-based decisions.

Cambridge, United States
January 2026
$250.0M
Series D

Founder Contacts

19,000+ verified contacts

HardwareManufacturingMedical DeviceSoftware

Lumafield develops industrial computed tomography (CT) solutions for non-destructive testing and inspection for engineers.

Cambridge, United States
November 2025
$50.0M
Debt Financing

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

South San Francisco, United States
October 2025
$250.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore Kleiner Perkins's Full Portfolio

View all companies funded by Kleiner Perkins across every industry and funding stage.

View Full Kleiner Perkins Portfolio